pentamidine has been researched along with Brain Neoplasms in 2 studies
Pentamidine: Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects.
pentamidine : A diether consisting of pentane-1,5-diol in which both hydroxyl hydrogens have been replaced by 4-amidinophenyl groups. A trypanocidal drug that is used for treatment of cutaneous leishmaniasis and Chagas disease.
Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pentamidine treatment suppressed proliferation and stemness in glioma-initiating cell lines." | 5.91 | Therapeutic potential of pentamidine for glioma-initiating cells and glioma cells through multimodal antitumor effects. ( Hirai, N; Hirao, A; Ichinose, T; Jiapaer, S; Kinoshita, M; Kobayashi, M; Nakada, M; Sabit, H; Tamai, S; Tanaka, S, 2023) |
| "Balamuthia mandrillaris meningoencephalitis is a rare but often fatal infection; only 2 survivors have been reported to date worldwide." | 2.42 | Balamuthia mandrillaris meningoencephalitis in an immunocompetent patient: an unusual clinical course and a favorable outcome. ( Chang, HT; Jung, S; Schelper, RL; Visvesvara, GS, 2004) |
| "Pentamidine treatment suppressed proliferation and stemness in glioma-initiating cell lines." | 1.91 | Therapeutic potential of pentamidine for glioma-initiating cells and glioma cells through multimodal antitumor effects. ( Hirai, N; Hirao, A; Ichinose, T; Jiapaer, S; Kinoshita, M; Kobayashi, M; Nakada, M; Sabit, H; Tamai, S; Tanaka, S, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tamai, S | 1 |
| Ichinose, T | 1 |
| Jiapaer, S | 1 |
| Hirai, N | 1 |
| Sabit, H | 1 |
| Tanaka, S | 1 |
| Kinoshita, M | 1 |
| Kobayashi, M | 1 |
| Hirao, A | 1 |
| Nakada, M | 1 |
| Jung, S | 1 |
| Schelper, RL | 1 |
| Visvesvara, GS | 1 |
| Chang, HT | 1 |
1 review available for pentamidine and Brain Neoplasms
| Article | Year |
|---|---|
Balamuthia mandrillaris meningoencephalitis in an immunocompetent patient: an unusual clinical course and a favorable outcome.
Topics: Aged; Animals; Brain Neoplasms; Central Nervous System Protozoal Infections; Clarithromycin; Diagnos | 2004 |
1 other study available for pentamidine and Brain Neoplasms
| Article | Year |
|---|---|
Therapeutic potential of pentamidine for glioma-initiating cells and glioma cells through multimodal antitumor effects.
Topics: Animals; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Glioblastoma; Glioma; Hum | 2023 |